|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.910 USD | -4.87% |
|
-5.33% | -31.04% |
| 07-30 | MannKind Corporation - Special Call | |
| 07-30 | MannKind Top-Line Data From Phase 1b INFLO-1 Study 'Positive,' Wedbush Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.25B | - | - | - | ||
| 56.54B | |||||
| 53.6B | |||||
| 22.91B | - | ||||
| 21.37B | - | ||||
| 20.27B |
- Stock Market
- Stocks
- MNKD Stock
- Charts MannKind Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
